Alexandre G. de Brevern is a Senior Researcher at INSERM and heads the DSIMB - Dynamics of Structures and Interactions of Macromolecules in Biology team of INSERM UMR_S 1134 BIGR unit. With nearly 20 years of experience in structural bioinformatics, his research focuses on developing tools for protein behavior analysis and applying these methods to disease-related proteins. He has created over 20 tools and authored more than 175 publications. Dr. de Brevern specializes in protein conformations, structural modeling, and drug design.

Clément Cochain received his PhD from Université Paris 7 in 2011. His doctorate work was performed in the Paris Cardiovascular Research Center under the supervision of J-S Silvestre, and focused on the role of chemokines and their receptors in the initiation and resolution of inflammation during tissue repair after ischemic injury. In 2012, he moved to the lab of Prof. Alma Zernecke (Würzburg, Germany) where he worked on the immune pathogenesis of atherosclerosis, with projects investigating various aspects of the adaptive and innate immune response in vascular inflammation.

Michel Sadelain is a genetic engineer and cell therapist at Memorial Sloan Kettering Cancer Center (MSKCC) in New York, where he holds the Steve and Barbara Friedman Chair. He is the founding director of the Center for Cell Engineering and a pioneer in T cell engineering and chimeric antigen receptor (CAR) therapy.

Agnes Lehuen is director of the Team “Immunology of diabetes” at Cochin Institute and University Paris City, France. She is cofounder of the Laboratory of Excellence INFLAMEX.